Researchlabnet

A new found path, rough and foggy may be the only hope

Clinical Trials, Research & Innovations

Research studies are the basis for evidence-based medicine, but they are not flawless. While there are inherent problems in conducting research, such as those unavoidable confounding variables, conclusions or interpretations may also disagree, and the researchers working on it are also subject to scrutiny. Study results can be manipulated for various conflicts of interests like when a new drug or product’s FDA approval is at stake, or results can be skewed to gain further grants and continue influx of fundings. Luckily when there is bad work, there is always a countering good work by authorities who are constantly monitoring and eventually retracting flawed studies.

Research studies at some points, also confuse rather than help. RLabNet fellows are certainly aware of these limitations. There are many types of research studies. While epidemiological and observational studies are inexpensive, the gold standard type is Randomized Controlled Trials (RCT), which is deemed more reliable and considered the main core reference of evidence-based medicine (EBM). Most new drugs undergo this RCT study type which we also called clinical trials.
Having known research limitations, and so with evidence-based Medicine (EBM); RLabNet fellows have come up with some helpful tips on how to figure out the trustworthiness of a report or research paper. Look at the size and time frame of the study. The bigger the size (thousands versus less than thirty subjects), the better. And the longer the time frame, the better to give time also, to observe for the long-term drug’s adverse effects. In regard to the study results, P value referred as statistical significance (a statistical gauge) on the finding was what matters most, until the late 20th century which has spurred controversies from some researchers’ analyses. Clinical importance or significance has been a debated issue versus statistical significance. A trend, though worth considering to some, isn’t enough. Also, the more consistent the findings, the better. Repetition, which suggests consistency, is when the initial study result agree with the second study or all follow-up studies. Additional measure is Confidence Interval which is a precision gauge. For instance, if a new formulated skin solution heals wounds at 5 to 7 days, the 95% Confidence Interval should remain consistent at 5 to 7 days rather than loose at 5 to 50 days, to be precise. In the latter case, the skin solution could not have worked at all, and skin healing likely took the natural course of healing after 20 to 50 days.

Having been diagnosed with rare or incurable disease, browsing the web can help find many institutions that have ongoing studies on new drugs or treatment approaches on various diseases. One easy way to go is through the ‘Catalogue’ of research online at clinicaltrials.gov. Other authorities and resources are public websites like cdc.gov, nih.gov and NCI’s cancer.gov. Additionally, huge educational healthcare authorities like UCLA Health, USC Keck Medicine, City of Hope, Mayo Clinic, Cleveland Clinic, Hopkins Medicine, Harvard Health and more, have various clinical trials on their respective websites. Before you enroll, talk to a doctor you trust who’s not involved in the research to get an unbiased opinion on what you are to gain or lose. And if you still need further assistance, you can always contact us on the Contact Page, check on Clinical Trials. and write up your issues and / or queries on the Comments & Messages blank box. We can help find your physician trustee.

RLabNet conducts in -house  studies and collaborate with other research  sponsors and administrators. If you register to the RLabNet research database, you may receive communications from us about ongoing research studies that may interest or matter to you.  Our database works as an extended resource especially in matters of urgency, and  do not enlist by name but by clinical case with highlighting. If you decide to be a RLabNet research participant , you  make a difference  by helping  further health information. What we learn, discover today maybe the only hope we have in the future’s unsettling health conditions.

Take the first step, register to be part of RLabNet research database. It is easy and click on the link below to learn more. There is no obligation nor cost involved.

Required information to fill in on research participant registration
Well-Being Applicant – Name / Address/ Email address/ Phone number / DOB (date of birth)

– Must have had no major health issues in the past 2 years.

CASE Participant – Name / Address/ Email address/ Phone number / DOB (date of birth)

– Must have an ailment that is subject of the study

*Research studies usually have few months to two years for recruitment periods and the time frames are posted online during the process. RLabNet Bulletin will have postings of ongoing studies (in-house or outside affiliate) on various subjects of interest.

Research studies are also the roots for innovation. Creating new solutions,new drugs or devices which are fueled by data from clinical research trials and /or experimentations. At times, one does not have to be a rocket scientist or medical expert to create, invent. Enormous information from self- study can also fuel ideas to brilliant innovations!

Airborne Supplements, Anyone?

We love Airborne supplement formulation because it was our same kind of idea-formulation that we contemplated to launch in the early 1990s. We observed remarkable improvement of symptoms on our friends, clients and patients from time to time, using our Airborne-alike supplements in two different forms – as add-up to soups or drinks. Symptoms of colds like headaches, sore throats and runny nose eased up, and improved productivity on coworkers without prolonged call-in sick days. Our excitement went off when the colds supplemental idea came up in the market ahead of us. A teacher thought of the same supplemental idea and introduced her product to Trader Joe’s customers. Nevertheless, Airborne became a subject of our continual observation on how the public would accept the formulation, and Airborne sales  went off exponentially. The test of time determines the supplemental formulation’s worth in the market. Though Airborne creator was fined for false-advertising controversy in 2008, Airborne are still sitting on every shelf of pharmaceuticals – big or small.  Giant pharmaceuticals came up with their own brands of Airborne-copycats. People buy when they are helped repeatedly.

INNOVATIONS are usually headed for patent application to avoid patent grants fall to other early bird applicants with same ideas. There are tons of medical research databases worldwide, but not all are great works or useful in the clinics nor in lab diagnostic fields. Regardless, brilliant researchers- explorers are our heroes in the healthcare industries. They are the reasons and hopes for new findings and treatments.
One out of every four patents is born in California. More than 200,000 patent applications were filed across the 50 states in 2022. California, home to Silicon Valley ‘s tech industry, is the #1 state for patents filed in 2022. It’s the home base for massive companies such as Apple, Google, and Facebook, where multibillion-dollar research budgets buoy innovation. Many states leading the race to patent inventions are also technology hubs. – US Patent and Trademark Office & Census Bureau population estimates

‘New inventions are plenty, but few live up to its novel use ‘

Human Insulin ( Humulin ) is one of the greatest medical, biotech invention of significant novel use. Gone are the days of adverse or allergic reactions from use of insulin derived from pancreases of pigs and cows . Diabetics are in a better place after Humulin, a bioengineered human insulin was created by City Of Hope researchers -inventors : Keiichi Itakura, Ph.D. and Arthur Riggs, Ph.D., in 1979.

People used to connote bacteria in the past as negatives or harmful but the fact is we also have ‘friendly bacteria’ not only around us, but also those that co-exist in our bodily system, like the probiotics guys. Itakura and Riggs made use of friendly bacteria like yeast as host to produce the human- alike insulin, by inserting genes code of human insulin to these hosts and ‘kicking’ them to reproduce human insulin. The harvested human insulin ( Humulin-N) is formulated to have a slower onset of action than regular insulin and a longer duration of activity (slightly less than 24 hours). Genentech (the first American biotechnology company) developed this recombinant DNA technology for mass production and Humulin-N was licensed to Eli Lilly by FDA in Oct 1982, for mass distribution. -Wikipedia

Theranos founder Elizabeth Holmes

Theranos’ 4.5 billion worth innovation hype reduced to zero.

Groundbreaking discoveries are exciting, however there are hyped inventions as well. We had been skeptical about Theranos’ hyped mini blood test technology over a decade ago. While it constantly plugged their blood test analyzer could conduct comprehensive blood tests from finger drops of blood, our affiliate scientists and associates just didn’t buy the idea at the time. Majority’s opinion was, it would take another ten years or so, to get something working with precision, using tiny drops of blood.  Additionally, Theranos’ patent was taking years for over a decade to process their blood tech idea. Skeptics of the alleged technology proved right when all dominoes fell in chain reaction.  Stanford professor John Ioannidis reported in the Journal of the American Medical Association (JAMA) that NO peer-reviewed research from Theranos had been published in medical research literature. University of Toronto Professor Eleftherios Diamandis  analyzed and  concluded  that  most  of  the  company’s  claims  were exaggerated.   In October same year- John Carreyrou of  The Wall Street Journal (WSJ)  reported  that Theranos was  just  using  traditional  blood  testing machines instead of the company’s own hyped  Edison  devices to run its tests. A whistleblower worker eventually reported the company’s irregularities  to  the  New York  State Department of Health.  Series of inspection, lawsuits and settlements followed after the WSJ story. Founder Elizabeth Holmes and software engineer Ramesh Balwani were eventually indicted on multiple counts of wire fraud and conspiracy to commit wire fraud. Investors, doctors and patients were defrauded. Holmes was found guilty and was sentenced 11 years and 3 months in prison. On May 30, 2023, she began serving her sentence at Federal Prison Camp, Bryan in Bryan, Texas. -Wikipedia.

Some popular ideas are not patentable for being obvious.

The Ziplines have been popular touring attractions since the 1990s. While many don’t have the nerve to be gliding afloat at immense heights, brave seniors or even centenarians zipped in flight on the record!

The amazing and daring Betty Hartman in flight with the zipline during her 92nd birthday!

The idea of Zipline is around thousands of years ago as a mode of transporting goods or mode of transportation. Despite the centuries-long history of ziplines with various uses, modern zipline recreational courses can trace their origins back to 1995, when Canadian entrepreneur Darren Hreniuk built the world’s first recreational zipline course in Monteverde, Costa Rica. Although he tried to patent the concept and aggressively block rival course from opening, the courts ultimately ruled that zipline recreational technology are not patentable and belong in the public domain.

Over time, ziplining became a hugely popular tourist activity in Costa Rica and it has since-in 1995, spread all around the globe.

Today, 72 countries boast recreational zipline courses. – wikipedia

celebrity cruises.com / courtesy

The fun fact is earlier in 1986, the thrill of ziplining as a recreative sport activity was an idea introduced and featured eventually as one of the sport contests during the REACT ‘s 1991 regional sport fest held in Lucena city, Philippines.

RLabNet fellow, a previous REACT operative ziplining for fun and thrill during the REACT Sport Fest.